Trade Bioventus Inc. - BVS CFD

Add to favourite

11.19

0.99%

View detailed chart

To be able to trade stocks like this, create an account and apply for a stock listing.

Create Account

Summary
Historical Data

Trading сonditions

Spread

0.08

Long position overnight fee

-0.024151%

Short position overnight fee

0.001929%

Overnight fee time

22:00 (UTC)

Min traded quantity

Currency

USD

Margin

5.00%

Stock exchange

United States of America

Commission on trade

Key Stats

Prev. Close	11.08
Open	11.05
1-Year Change	194.67%
Day's Range	10.95 - 11.24

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Nov 15, 2024	11.19	0.21	1.91%	10.98	11.25	10.91
Nov 14, 2024	11.08	0.00	0.00%	11.08	11.36	10.97
Nov 13, 2024	11.12	-0.71	-6.00%	11.83	11.84	11.03
Nov 12, 2024	11.79	-0.60	-4.84%	12.39	12.51	11.47
Nov 11, 2024	12.41	0.45	3.76%	11.96	12.52	11.80
Nov 8, 2024	11.78	0.51	4.53%	11.27	11.81	11.27
Nov 7, 2024	11.19	0.05	0.45%	11.14	11.27	10.86
Nov 6, 2024	11.22	-0.73	-6.11%	11.95	12.55	10.74
Nov 5, 2024	11.43	3.23	39.39%	8.20	11.47	7.18
Nov 4, 2024	13.68	0.16	1.18%	13.52	14.32	13.29
Nov 1, 2024	13.55	0.11	0.82%	13.44	13.96	13.44
Oct 31, 2024	13.52	0.05	0.37%	13.47	13.58	13.30
Oct 30, 2024	13.53	0.39	2.97%	13.14	13.67	13.14
Oct 29, 2024	13.26	0.36	2.79%	12.90	13.26	12.70
Oct 28, 2024	13.01	-0.19	-1.44%	13.20	13.49	12.97
Oct 25, 2024	13.18	-0.04	-0.30%	13.22	13.42	12.97
Oct 24, 2024	13.30	0.00	0.00%	13.30	13.58	13.17
Oct 23, 2024	13.24	0.47	3.68%	12.77	13.24	12.77
Oct 22, 2024	12.92	0.29	2.30%	12.63	12.93	12.63
Oct 21, 2024	12.69	-0.08	-0.63%	12.77	12.99	12.58

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

1:1
2:1
3:1
5:1
10:1
20:1

Leverage

20:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Bioventus Inc. Company profile

About Bioventus Inc

Bioventus Inc is a global medical device company. The Company is focused on developing and commercializing clinically and minimally invasive treatments that engage and enhance the body’s natural healing process. The Company’s portfolio of products includes OA joint pain treatment and joint preservation, bone graft substitutes and minimally invasive fracture treatment. The OA joint pain treatment and joint preservation is focused on orthopedics. Its bone graft substitutes (BGSs) offers portfolio of products including human tissue allografts and synthetics. Its BGS products can be used in conjunction with any orthopedic fixation and spinal fusion implant. They are designed to improve bone fusion rates following spinal fusion and other orthopedic surgeries and reduce the need for using the patient’s own bone.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Bioventus Inc revenues increased 34% to $430.9M. Net income applicable to common stockholders increased from $4.4M to $19.4M. Revenues reflect U.S. segment increase of 32% to $387.6M, International segment increase of 58% to $43.3M. Net income benefited from Stock-based Compensation in SGA decrease from $10.1M (expense) to $4.5M (income), Foreign Exchange Gain/Loss increase of 13% to $132K (income).

Industry:

Medical Equipment

4721 Emperor Boulevard, Suite 100
DURHAM
NORTH CAROLINA 27703
US

News

Shiba Inu coin price prediction 2030: could Shiba Inu coin reach $1? Third party price target

Can Shiba Inu reinvent itself to become a worthy long-term investment?

08:36, 15 November 2024

Trump trades charge as Bitcoin hits $US80,000

Bitcoin hits $80,000 amid expectations of fiscal stimulus, lower regulatory risks, and resilient US economy.

10:48, 13 November 2024

Australian jobs data expected to point to solid labour market conditions

Australian labour market and wage data to reveal job growth resilience, shaping RBA rate cut expectations and impacting AUD amidst global economic shifts.

10:16, 13 November 2024

FOMC cuts interest rates as expected and sticks to its line on future policy

The FOMC cut interest rates by 25 basis points at its November meeting, aligning with expectations. Wall Street hit record highs following the decision, with tech stocks leading the rally. Markets are pricing in a probable December cut amid resilient economic indicators.

13:33, 8 November 2024

FOMC and BOE preview: further rate cuts expected

Both the Federal Reserve and the Bank of England are expected to cut rates further when they meet later this week.

14:14, 5 November 2024

RBA meeting preview: No change to policy expected as inflation fight continues

The Reserve Bank of Australia is expected to keep its cash rate on hold at 4.35% when it announces its policy decision at 2.30PM on the 5th of November, 2024. Despite ongoing evidence of soft demand, upside risks to inflation are likely to remain the central bank’s primary concern.

13:35, 4 November 2024